Facilitates the acquisition of high-quality, accurate-mass data for routine small molecule applications SmartMS technology helps speed decision-making and delivers confidence with consistent, ...
New LC-MS system delivers accurate and reproducible results for multi-attribute monitoring of biologics. Eliminates analyte-to-metal surface interactions greatly enhancing recovery of hard-to-detect ...
Waters Corporation WAT launched an integrated high-resolution liquid chromatography mass spectrometry (LC-MS) system, namely the Waters BioAccord System with ACQUITY Premier. The BioAccord System ...
Waters Corporation (NYSE:WAT) has released the ACQUITY RDa™ Detector featuring SmartMS™, the company’s newest time-of-flight (TOF) mass spectrometer (MS) for small molecule analysis for pharmaceutical ...
Waters Corporation (NYSE:WAT) today introduced the Waters™ BioAccord™ System with ACQUITY™ Premier, a combination of the Waters BioAccord System and the breakthrough ACQUITY Premier UPLC™ with ...
Facilitates the acquisition of high-quality, accurate-mass data for routine small molecule applications SmartMS technology helps speed decision-making and delivers confidence with consistent, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results